The Patterson Perspective

With 35+ years of orthopedic sales experience, Thurman Ballard joins Tetrous to drive adoption of its groundbreaking bone-to-tendon healing technology.

Utah partners with YouScience to launch a system ensuring every student graduates with a valuable 'first credential' tied to in-demand, high-wage careers.

A groundbreaking study proves a botanical compound enhances protein absorption, leading to measurable gains in muscle strength and mass, especially for older adults.

RA Capital's major investment extends Karyopharm's runway, but future funding is now directly tied to the outcome of its pivotal endometrial cancer trial.

Armis sweeps key Global InfoSec Awards at RSAC 2026 with its AI-powered Centrix™ platform, signaling a new era in cyber exposure management.

Amid rising storm damage and insurance demands, one AI startup is expanding nationally with tech that promises to transform how roofs are inspected and repaired.

Italian spirits icon Branca International invests in ALTR's radical tech, aiming to redefine drinking without sacrificing taste. A new era is brewing.

Splitit's new mobile solution lets contractors and doctors offer installments on existing credit cards, targeting a $4.6 trillion face-to-face market.

Fransmart appoints marketing expert Sara Schmillen, who will lead an all-women team to find and grow the next generation of powerhouse franchise brands.

With deep roots in health-system leadership and accreditation, Samuel Calabrese is set to guide the nation's largest pharmacy group through key challenges.

The iconic seafood brand is betting on the 'sweet heat' craze to reinvent a classic, signaling a major strategic shift in the premium seafood market.

As Elev8 New Media returns to the ROTH Conference, their role highlights why specialized PR is a non-negotiable asset for growth companies seeking capital.

Health-Ade's new campaign with Lindsay Lohan is more than celebrity sparkle; it's a calculated play for the booming wellness market. Here's the inside story.

The Ontario Real Estate Association is calling for a radical overhaul of development charges to tackle housing affordability. Will it work?

Aldeyra Therapeutics' dry eye drug, reproxalap, was rejected by the FDA for a third time, citing inconsistent data and wiping out millions in value.

As Xsolla SPAC 1's shares and warrants begin separate trading, the firm's expert team starts its search for a billion-dollar target in gaming and fintech.

A real-life iguana stowaway from Desert Storm inspires an interactive quest on the USS Missouri, blending history with adventure for a new generation.

In a bold $440M move, GO Residential REIT acquires two more luxury towers, capping an $820M two-week shopping spree in NYC's hot rental market.

A new report shows how a Canadian app saved 7 million pounds of food, offering a solution to rising grocery bills and a massive environmental crisis.

VNET smashes 2025 revenue goals on AI demand, but a net loss and huge capex plan raise questions about its high-stakes growth strategy in China.